Biotech

All Articles

Repare lays off 25% of team as biotech stops preclinical R&ampD

.Repare Therapeutics is actually laying off a fourth of its own workforce as the oncology biotech sc...

J &amp J declare FDA approval of $6.5 B autoimmune drug

.Johnson &amp Johnson has actually taken one more action toward understanding a profit on its own $6...

Gain's stage 1 gain paves way to show Parkinson's medication's worth

.Increase Rehabs has established its sights on verifying the efficiency of its Parkinson's disease t...

Actinogen reports brand new stage 2 data to salvage anxiety drug

.Actinogen Medical's hopes-- and also stock rate-- have rebounded a little coming from previously th...

Pfizer as well as Flagship include Ratio to multibillion-dollar formula

.Front Runner Pioneering and also Pfizer have actually included Ratio right into their 10-program co...

Bayer markers $547M treaty to push perimeters of noncoding RNA

.Bayer managers were interested to anxiety to Brutal this summer season that the German pharma giant...

UK unveils programs to launch 18 new medical test hubs

.Among a yearslong medical trial downtrend in the U.K., a brand new public-private alliance has deve...

UPDATE: Genentech telegraphs 93 cutbacks in California after discussing strategies to shutter cancer cells immunology research system

.Following the announcement of a sizable unemployment round in April and also a major restructuring ...

Neurocrine's KarXT opponent attacks in stage 2-- but only at low dosage

.Neurocrine Biosciences has accomplished its hoped-for account in a stage 2 schizophrenia trial, pro...

Vaderis' rare blood vessel ailment medication minimizes nosebleeds

.Vaderis Rehabs' target to build the very first medicine targeted exclusively at a particular unusua...